BR112017010475A2 - cepas de lactobacillus ou bifidobacterium para manter homeostase - Google Patents

cepas de lactobacillus ou bifidobacterium para manter homeostase

Info

Publication number
BR112017010475A2
BR112017010475A2 BR112017010475A BR112017010475A BR112017010475A2 BR 112017010475 A2 BR112017010475 A2 BR 112017010475A2 BR 112017010475 A BR112017010475 A BR 112017010475A BR 112017010475 A BR112017010475 A BR 112017010475A BR 112017010475 A2 BR112017010475 A2 BR 112017010475A2
Authority
BR
Brazil
Prior art keywords
composition
strains
lactobacillus
bifidobacterium
human body
Prior art date
Application number
BR112017010475A
Other languages
English (en)
Inventor
Mogna Giovanni
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of BR112017010475A2 publication Critical patent/BR112017010475A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção se refere a cepas selecionadas de bactérias pertencentes ao gênero lactobacillus e bifidobacteria que têm capacidade de manter uma condição de homeostase de longa duração em um corpo humano. ademais, a presente invenção se refere a uma composição, por exemplo, uma composição alimentícia, um produto de suplemento, uma composição para um dispositivo médico ou uma composição farmacêutica para uso no tratamento de uma condição de homeostase de longa duração em um corpo humano; ou para uso no tratamento de insuficiência renal, preferencialmente aguda ou crônica; ou para uso na redução de toxinas urêmicas, preferencialmente de origem bacteriana, tais como indol e/ou cresol.
BR112017010475A 2014-11-26 2015-11-26 cepas de lactobacillus ou bifidobacterium para manter homeostase BR112017010475A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20142035 2014-11-26
PCT/IB2015/059146 WO2016084029A1 (en) 2014-11-26 2015-11-26 Strains of lactobacillus or bifidobacterium for maintaining homeostasis

Publications (1)

Publication Number Publication Date
BR112017010475A2 true BR112017010475A2 (pt) 2018-04-03

Family

ID=52463032

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017010475A BR112017010475A2 (pt) 2014-11-26 2015-11-26 cepas de lactobacillus ou bifidobacterium para manter homeostase

Country Status (9)

Country Link
US (1) US20170326186A1 (pt)
EP (1) EP3223836A1 (pt)
JP (2) JP2017536828A (pt)
KR (1) KR20170084127A (pt)
CN (1) CN109496234A (pt)
BR (1) BR112017010475A2 (pt)
CA (1) CA2967219A1 (pt)
RU (1) RU2730005C2 (pt)
WO (1) WO2016084029A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2551642B (en) 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
FR3062396A1 (fr) * 2017-01-27 2018-08-03 Ninapharm Composition de metabolites issus de la fermentation d'ingredients bio-sources a partir de microbiotes de centenaires ayant des proprietes anti-inflammatoires et d'augmentation de l'activite mitochondriale
IT201700068000A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione di batteri e/o loro derivati la cui attività biologica è stata specificatamente studiata per il miglioramento dello stato di salute differenziato per maschi e femmine
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
WO2019117654A1 (ko) 2017-12-15 2019-06-20 (주)녹십자웰빙 신장질환 진행 억제 및 예방용 프로바이오틱스 및 이를 포함하는 신장질환 진행 억제 및 예방용 조성물
CA3085855A1 (en) * 2017-12-19 2019-06-27 Probiotical S.P.A. Composition for use in the treatment and/or improvement of sleep and mood disorders
CA3085977A1 (en) * 2017-12-19 2019-06-27 Probiotical S.P.A. Composition for use in the treatment and/or improvement of sleep and mood disorders
JP2021101645A (ja) * 2019-12-25 2021-07-15 株式会社明治 免疫バランスの調節のための組成物
KR102441174B1 (ko) * 2020-01-31 2022-09-08 부경대학교 산학협력단 쌀가루를 이용한 이소말토올리고당을 함유하는 신바이오틱스의 제조방법
IT202000020545A1 (it) * 2020-08-27 2022-02-27 Mofin S R L Composizione di ceppi di batteri etero-fermentanti, loro uso per la lievitazione di prodotti della panificazione, prodotti della panificazione e procedimenti per la loro preparazione
IT202100015398A1 (it) * 2021-06-11 2022-12-11 Probiotical Spa Ceppi di batteri probiotici per uso in un metodo di trattamento preventivo o in un metodo di trattamento coadiuvante per le infezioni respiratorie virali
IT202100016055A1 (it) * 2021-06-18 2022-12-18 Univ Degli Studi Di Camerino Composizione comprendente estratto secco di contenuto intestinale di polli adulti liofilizzato, relativo uso come integratore alimentare e relativo uso per stimolare il sistema immunitario
CA3233195A1 (en) * 2021-10-01 2023-04-06 Dong-Hyun Kim Novel probiotics and use thereof
TWI797881B (zh) * 2021-12-08 2023-04-01 豐華生物科技股份有限公司 抗老化組合物及其延緩衰老的用途
IT202200011519A1 (it) * 2022-05-31 2023-12-01 Synbiotec S R L Composizione comprendente una miscela di microorganismi probiotici per uso in un metodo per la prevenzione e/o il trattamento dell’inflammaging
CN116585360B (zh) * 2023-05-24 2023-11-14 微康益生菌(苏州)股份有限公司 一种改善慢性肾病的益生菌剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026160B2 (en) * 1999-04-30 2006-04-11 Kibow Biotech, Inc. Oral bacteriotherapy compositions and methods
US6706287B2 (en) * 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
CA2540467C (en) * 2003-09-30 2013-11-12 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
ITTO20070555A1 (it) * 2007-07-26 2009-01-27 Bioman S R L Biomassa arricchita in zinco, procedimento per la sua preparazione e prodotti probiotici, cosmetici, dietetici e nutraceutici comprendenti tale biomassa
ITMI20080898A1 (it) * 2008-05-16 2009-11-17 Probiotical Spa Uso di batteri probiotici per il trattamento della iperomocisteinemia
JP2009102324A (ja) * 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
JP2011254773A (ja) * 2010-06-11 2011-12-22 Bio Plan:Kk 乳酸菌の菌株及びこれを利用したアレルギー抑制剤
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20120471A1 (it) * 2012-03-26 2013-09-27 Giovanni Mogna Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
ITMI20121328A1 (it) * 2012-07-30 2014-01-31 Probiotical Spa Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine.
MX367504B (es) * 2013-03-21 2019-07-31 Nutrimentos Inteligentes S A De C V Mezcla gelatinosa de probióticos y prebióticos con acción simbiótica sinérgica para el tratamiento de enfermedad renal crónica.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat

Also Published As

Publication number Publication date
KR20170084127A (ko) 2017-07-19
US20170326186A1 (en) 2017-11-16
CA2967219A1 (en) 2016-06-02
RU2017120146A (ru) 2018-12-26
EP3223836A1 (en) 2017-10-04
RU2730005C2 (ru) 2020-08-14
JP2017536828A (ja) 2017-12-14
CN109496234A (zh) 2019-03-19
JP2021006562A (ja) 2021-01-21
RU2017120146A3 (pt) 2019-06-14
WO2016084029A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
BR112017010475A2 (pt) cepas de lactobacillus ou bifidobacterium para manter homeostase
MY186217A (en) Mixture of hmos
PH12017501342A1 (en) Glycan therapeutics and related methods thereof
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
BR112014025469A2 (pt) uso de bactérias probióticas no tratamento de infecções bacterianas e regeneração da pele, bem como composições compreendendo cepas das referidas bactérias
MX2015006491A (es) Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
BR112015024330A2 (pt) nova bactéria do ácido láctico, medicamento, alimento ou bebida, e ração que contenham a nova bactéria do ácido láctico
WO2016063263A3 (en) Methods and products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker
MX2017014787A (es) Poblaciones bacterianas para promover la salud.
MX2016014807A (es) Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados.
PH12019502340A1 (en) Probiotic molecules for reducing pathogen virulence
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
BR112016018283A2 (pt) Composição que compreende bifidobacterium animalis ssp. lactis
BR112015022833A2 (pt) bactéria de ácido láctico ou um fragmento da mesma, bactéria de ácido láctico isolada ou um fragmento da mesma, uso de bactérias de ácido láctico ou um fragmento das mesmas, composição alimentícia, método para conservação de gêneros alimentícios, e, método de identificação de uma bactéria de ácido láctico
MX2015015518A (es) Metodos y composiciones para el tratamiento del cancer.
BR112018007560A2 (pt) composição cosmética tendo bactérias probióticas
BR112018014654A2 (pt) cepa inovadora de bactérias probióticas e composições e usos da mesma
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
BR112017012251A2 (pt) cepas probióticas que têm capacidade absorvente de colesterol, métodos e usos das mesmas
PE20190122A1 (es) Uso de cepas bacterianas pertenecientes a la especie lactobacillus kefiri en pediatria para generar y/o mantener un estado de homeostasis
PH12017502042A1 (en) Dietary supplement
MY183171A (en) Composition containing bacterium belonging to genus lactobacillus
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements